Skip to main content

Articles

Page 27 of 29

  1. Little information is available on the effect of allergen-specific immunotherapy on airway responsiveness and markers in exhaled air. The aims of this study were to assess the safety of immunotherapy with puri...

    Authors: Luis Prieto, Ricardo Palacios, Dulce Aldana, Anna Ferrer, Carmen Perez-Frances, Victoria Lopez and Rocio Rojas
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:27
  2. Eosinophilic esophagitis (EoE) is characterized by the inflammation of the esophagus and the infiltration of eosinophils into the esophagus, leading to symptoms such as dysphagia and stricture formation. Syste...

    Authors: Jennifer J Huang, Jae Won Joh, Judy Fuentebella, Anup Patel, Tammie Nguyen, Scott Seki, Lisa Hoyte, Neha Reshamwala, Christine Nguyen, Anthony Quiros, Dorsey Bass, Eric Sibley, William Berquist, Kenneth Cox, John Kerner and Kari C Nadeau
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:25
  3. We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angio...

    Authors: Tom Bowen, Marco Cicardi, Henriette Farkas, Konrad Bork, Hilary J Longhurst, Bruce Zuraw, Emel Aygoeren-Pürsün, Timothy Craig, Karen Binkley, Jacques Hebert, Bruce Ritchie, Laurence Bouillet, Stephen Betschel, Della Cogar, John Dean, Ramachand Devaraj…
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:24
  4. Advances in understanding the pathophysiology and mechanism of swelling in hereditary angioedema (HAE) has resulted in the development of multiple new drugs for the acute and prophylactic treatment of patients...

    Authors: Bruce L Zuraw
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:23
  5. Hereditary angioedema (C1 inhibitor deficiency, HAE) is associated with intermittent swellings which are disabling and may be fatal. Effective treatments are available and these are most useful when given earl...

    Authors: Hilary J Longhurst, Henriette Farkas, Timothy Craig, Emel Aygören-Pürsün, Claire Bethune, Janne Bjorkander, Konrad Bork, Laurence Bouillet, Henrik Boysen, Anette Bygum, Teresa Caballero, Marco Cicardi, John Dempster, Mark Gompels, Jimmy Gooi, Sofia Grigoriadou…
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:22
  6. Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed.

    Authors: Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, Eva Rusicke, Thomas Klingebiel and Wolfhart Kreuz
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:21
  7. C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadi...

    Authors: Tom Bowen, John Brosz, Kristylea Brosz, Jacques Hebert and Bruce Ritchie
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:20
  8. Women with hereditary angioedema (HAE) are more likely to be symptomatic that men. Hormonal factors (puberty, contraception, pregnancy,....) play a significant role in the precipitation or worsening of the con...

    Authors: Laurence Bouillet
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:17
  9. Acquired angioedema (AAE) is characterized by acquired deficiency of C1 inhibitor (C1-INH), hyperactivation of the classical pathway of human complement and angioedema symptoms mediated by bradykinin released ...

    Authors: Marco Cicardi and Andrea Zanichelli
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:14
  10. Primary immune deficiency disorders (PIDs) are a group of diseases associated with a genetic predisposition to recurrent infections, malignancy, autoimmunity and allergy. The molecular basis of many of these d...

    Authors: Rohan Ameratunga, See-Tarn Woon, Katherine Neas and Donald R Love
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:12
  11. The current geriatric population in the United States accounts for approximately 12% of the total population and is projected to reach nearly 20% (71.5 million people) by 2030[1]. With this expansion of the numbe...

    Authors: Jayant M Pinto and Seema Jeswani
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:10
  12. T cell disorders have been poorly understood until recently. Lack of knowledge of underlying molecular mechanisms together with incomplete data on long term outcome have made it difficult to assess prognosis a...

    Authors: Theresa S Cole and Andrew J Cant
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:9

The official journal of CSACI

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.5
    Source Normalized Impact per Paper (SNIP): 0.904
    SCImago Journal Rank (SJR): 0.749

    Speed 2023
    Submission to first editorial decision (median days): 18
    Submission to acceptance (median days): 140

    Usage 2023
    Downloads: 1,545,686
    Altmetric mentions: 2,123